← Back to headlines
Jury finds Parse Biosciences willfully infringed Scale patents
A federal jury has ruled that Parse Biosciences willfully infringed upon patents held by Scale, potentially exposing the biotech firm to significant legal and financial liabilities.
28 Aug, 18:44 — 28 Aug, 18:44
Sources
Showing 1 of 1 sources
Related Stories
Fed Chair Warsh Signals Potential Rate Hike as Inflation Persists at Jackson Hole
22m ago
Zimmer Biomet and NXP Semiconductors Announce Quarterly Dividends
52m ago
Trump Announces Plan to Break Up Food Processing Monopolies
1h ago
Corporate Insiders Make Significant Stock Purchases Including Klarna CEO
2h ago